Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
language:"Undetermined"
topic_facet:"Medical Condition: Unresectable locally advanced or metastatic melanoma MedDRA version: 21.1Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 21.1Level: PTClassification code 10025669Term: Malignant melanoma stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps);Therapeutic area: Diseases [C] - Cancer [C04]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=language%3A%22Undetermined%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Unresectable+locally+advanced+or+metastatic+melanoma+MedDRA+version%3A+21.1Level%3A+LLTClassification+code+10065252Term%3A+Solid+tumorSystem+Organ+Class%3A+10029104+-+Neoplasms+benign%2C+malignant+and+unspecified+%28incl+cysts+and+polyps%29+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10025669Term%3A+Malignant+melanoma+stage+IISystem+Organ+Class%3A+10029104+-+Neoplasms+benign%2C+malignant+and+unspecified+%28incl+cysts+and+polyps%29%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=language%3A%22Undetermined%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Unresectable+locally+advanced+or+metastatic+melanoma+MedDRA+version%3A+21.1Level%3A+LLTClassification+code+10065252Term%3A+Solid+tumorSystem+Organ+Class%3A+10029104+-+Neoplasms+benign%2C+malignant+and+unspecified+%28incl+cysts+and+polyps%29+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10025669Term%3A+Malignant+melanoma+stage+IISystem+Organ+Class%3A+10029104+-+Neoplasms+benign%2C+malignant+and+unspecified+%28incl+cysts+and+polyps%29%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=language%3A%22Undetermined%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Unresectable+locally+advanced+or+metastatic+melanoma+MedDRA+version%3A+21.1Level%3A+LLTClassification+code+10065252Term%3A+Solid+tumorSystem+Organ+Class%3A+10029104+-+Neoplasms+benign%2C+malignant+and+unspecified+%28incl+cysts+and+polyps%29+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10025669Term%3A+Malignant+melanoma+stage+IISystem+Organ+Class%3A+10029104+-+Neoplasms+benign%2C+malignant+and+unspecified+%28incl+cysts+and+polyps%29%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (14)
1
Vemurafenib (vem), cobimetinib (cobi) & atezolizumab (atezo) triplet combination in advanced melanoma : A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUS COBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION-POSITIVE PATIENTS WITH METASTATIC OR UNRESECTABLE LOCALLY ADVANCED MELANOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
Vemurafenib (vem), cobimetinib (cobi) & atezolizumab (atezo) triplet combination in advanced melanoma : A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUS COBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION-POSITIVE PATIENTS WITH METASTATIC OR UNRESECTABLE LOCALLY ADVANCED MELANOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
Vemurafenib (vem), cobimetinib (cobi) & atezolizumab (atezo) triplet combination in advanced melanoma : A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUS COBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION-POSITIVE PATIENTS WITH METASTATIC OR UNRESECTABLE LOCALLY ADVANCED MELANOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Vemurafenib (vem), cobimetinib (cobi) & atezolizumab (atezo) triplet combination in advanced melanoma : A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUS COBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION-POSITIVE PATIENTS WITH METASTATIC OR UNRESECTABLE LOCALLY ADVANCED MELANOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Vemurafenib (vem), cobimetinib (cobi) & atezolizumab (atezo) triplet combination in advanced melanoma : A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OFATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUSCOBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION POSITIVE PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Vemurafenib (vem), cobimetinib (cobi) & atezolizumab (atezo) triplet combination in advanced melanoma : A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUS COBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION-POSITIVE PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Vemurafenib (vem), cobimetinib (cobi) & atezolizumab (atezo) triplet combination in advanced melanoma : A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OFATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUSCOBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION POSITIVE PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Vemurafenib (vem), cobimetinib (cobi) & atezolizumab (atezo) triplet combination in advanced melanoma : A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OFATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUSCOBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION POSITIVE PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
Vemurafenib (vem), cobimetinib (cobi) & atezolizumab (atezo) triplet combination in advanced melanoma : A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUS COBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION-POSITIVE PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
Vemurafenib (vem), cobimetinib (cobi) & atezolizumab (atezo) triplet combination in advanced melanoma : A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OFATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUSCOBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION POSITIVE PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Sprache: Unbestimmt
Filter aufheben
Thema: Medical Condition: Unresectable locally advanced or metastatic melanoma MedDRA version: 21.1Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 21.1Level: PTClassification code 10025669Term: Malignant melanoma stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps);Therapeutic area: Diseases [C] - Cancer [C04]
Medienart
14
Aufsätze
14
E-Artikel
14
E-Ressourcen
Zeitschriftentitel
14
WHO International Clinical Trials Registry Plat...
Thema
14
610
Medical Condition: Unresectable locally advance...
14
Phase: Phase 3
14
Recruitment Status: Authorised-recruitment may ...
14
Study Type: Interventional
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2022
4
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Unbestimmt
Haven't found what you're looking for?
Wird geladen...